Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B

计划入组 105 人 · 首次发布于 2013 年 7 月 24 日

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

计划入组 43 人 · 首次发布于 2021 年 7 月 28 日

Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

计划入组 114 人 · 首次发布于 2006 年 11 月 2 日

Peginterferon alpha-2b（Vir Biotechnology）

MSC-IFNα

ATP-IFNα

2A Pharma AB

Sweden

Lixte Biotechnology

United States

Per Humpert

Germany

ClearB Therapeutics Advances CLB-4000 Therapeutic Vaccine for Chronic Hepatitis B After Positive Sentinel Safety Review

Brii Bio's BRII-179 Shows Promise in Identifying Responders for HBV Functional Cure

Brii Biosciences' Combination Therapy Shows Promise for Hepatitis B Functional Cure in Phase 2 Study